We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -8.00 | -0.93% | 853.00 | 156,090 | 16:29:58 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 851.00 | 854.00 | 863.00 | 843.00 | 850.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Veterinary Svcs-animal Specs | 664.8M | 6.2M | 0.0864 | 98.73 | 617.68M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 17:00:25 | O | 1,762 | 850.14 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 29/11/2024 | 07:00 | UK RNS | CVS Group plc Total Voting Rights |
| 26/11/2024 | 13:59 | UK RNS | CVS Group plc Grant of Options & PDMR Dealing |
| 21/11/2024 | 16:05 | UK RNS | CVS Group plc Standard form for notification of major holdings |
| 20/11/2024 | 12:51 | UK RNS | CVS Group plc Result of AGM |
| 20/11/2024 | 11:17 | ALNC |  CVS to meet market expectations amid high need for veterinary care |
| 20/11/2024 | 07:00 | UK RNS | CVS Group plc AGM Statement and Trading Update |
| 04/11/2024 | 09:18 | UK RNS | CVS Group plc Standard form for notification of major holdings |
| 31/10/2024 | 11:35 | UK RNS | CVS Group plc Exercise of Options and Total Voting Rights |
| 30/10/2024 | 16:11 | UK RNS | CVS Group plc Standard form for notification of major holdings |
| 21/10/2024 | 09:42 | UK RNS | CVS Group plc Posting of Annual Report and Notice of AGM |
Cvs (CVSG) Share Charts1 Year Cvs Chart |
|
1 Month Cvs Chart |
Intraday Cvs Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 05/12/2024 | 18:49 | CVS Group: VETS,All things bright and beautiful | 973 |
| 07/10/2019 | 19:38 | Concerns founded? | 33 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-12-13 17:00:27 | 850.14 | 1,762 | 14,979.47 | O |
| 2024-12-13 17:00:27 | 849.97 | 1,762 | 14,976.47 | O |
| 2024-12-13 17:00:26 | 850.14 | 123 | 1,045.67 | O |
| 2024-12-13 17:00:26 | 849.97 | 123 | 1,045.46 | O |
| 2024-12-13 16:35:25 | 853.00 | 63,830 | 544,469.90 | UT |
| Top Posts |
|---|
Posted at 13/12/2024 08:20 by Cvs Daily Update Cvs Group Plc is listed in the Veterinary Svcs-animal Specs sector of the London Stock Exchange with ticker CVSG. The last closing price for Cvs was 861p.Cvs currently has 71,740,184 shares in issue. The market capitalisation of Cvs is £611,943,770. Cvs has a price to earnings ratio (PE ratio) of 98.73. This morning CVSG shares opened at 850p |
Posted at 20/11/2024 07:59 by waldron DividendSubject to shareholder approval at the AGM, CVS intends to pay its previously announced final dividend of 8.0 pence per ordinary share on 29 November 2024 to holders on the register as at 1 November 2024. The ex-dividend date was 31 October 2024. Outlook Whilst the Board remains mindful of headwinds in the UK, the fundamental need for high quality veterinary care remains strong, the expansion into Australia is progressing well and CVS remains well positioned to deliver attractive growth in shareholder value over the medium term. The recently announced UK government budget changes will result in a significant increase in employment costs with effect from April 2025. Whilst these increases will only apply in the final quarter of this financial year, the annualised impact to the year ending 30 June 2026 is estimated to be £8m from the national insurance scheme changes. The Group expects to substantially mitigate these through growth, efficiencies and purchasing synergies in Australia. The Board remains confident in the Group's ability to deliver full year 2025 results in line with market expectations. |
Posted at 08/10/2024 07:19 by waldron CVS Group (LON:CVSG) Shares Cross Above 200 Day Moving Average - Time to Sell?Written by MarketBeat October 4, 2024 CVS Group plc (LON:CVSG - Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,054.38 ($14.10) and traded as high as GBX 1,124 ($15.03). CVS Group shares last traded at GBX 1,064 ($14.23), with a volume of 349,914 shares changing hands. Get CVS Group alerts: Wall Street Analyst Weigh In Separately, Berenberg Bank reissued a "buy" rating and issued a GBX 2,370 ($31.70) price objective on shares of CVS Group in a research note on Thursday, July 25th. The company has a quick ratio of 0.90, a current ratio of 1.09 and a debt-to-equity ratio of 110.48. The firm has a market capitalization of £760.44 million, a P/E ratio of 2,905.56, a price-to-earnings-gr CVS Group Increases Dividend The company also recently disclosed a dividend, which will be paid on Friday, November 29th. Stockholders of record on Thursday, October 31st will be issued a dividend of GBX 8 ($0.11) per share. This is an increase from CVS Group's previous dividend of $7.50. The ex-dividend date of this dividend is Thursday, October 31st. This represents a dividend yield of 0.71%. CVS Group's payout ratio is currently 2,222.22%. Insider Activity at CVS Group In other CVS Group news, insider Richard Gray bought 1,600 shares of the firm's stock in a transaction dated Wednesday, July 10th. The stock was bought at an average cost of GBX 1,019 ($13.63) per share, with a total value of £16,304 ($21,808.45). 5.83% of the stock is currently owned by insiders. CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses. |
Posted at 26/9/2024 07:20 by wad collector Well that drop didn't last long ;about 15 minutes! Guess the lower numbers were all in the price. |
Posted at 26/9/2024 06:56 by waldron Latest DividendsSummary Previous dividend Next dividend Status Paid Declared Type Final Final Per share 7.5p 8p Declaration date 21 Sep 2023 (Thu) 26 Sep 2024 (Thu) Ex-div date 02 Nov 2023 (Thu) 31 Oct 2024 (Thu) Pay date 08 Dec 2023 (Fri) 29 Nov 2024 (Fri) DIVIDENDMAX |
Posted at 20/9/2024 14:03 by 1jat The truth is that the small local vets practices cannot cope with increasing investment required and management bandwidth to cover the full range of regulations vets have to comply with.The young vets want a well paid job rather than being the business owner, so the old partners sell up to a corporate to realise their practice value because no one else will buy into it. I think the CMA remedies will be about better price transparency to encourage shopping around….but the practicalities of getting pet medicine work against market pricing mechanisms except for routine pest control. It is a bit like supermarkets, the CMA keeps going back but cant reach a definite solution, so the big players carefully tiptoe around the market creating an oligopoly and squeezing the smaller players out. |
Posted at 24/5/2024 08:00 by roddyb cvs share price seems to be holding up better than I expected, maybe a tenner-a-share is a bottom? |
Posted at 16/3/2024 12:05 by wallywoo IVC Evidensia are the biggest player in the UK market with around 1000 UK locations (2500 worldwide). They are a private equity outfit, therefore, not mentioned in press. But are more then 5x the size of cvs (ww).To me, the trend towards larger groups is all about economies of scale, not about exploiting a monopoly (most small vets have a near monopoly in their location anyway). I think it is likely any competition authority will come to the same conclusion. Making these practices cut their price will just close the smaller, less efficient vets and not help the market. For those reasons I think this will recover over the next few months and have invested here yesterday at 1005. This share price drop could also attract a speculative bid imho. The USA are well ahead of UK, Europe, Australia with large vet groups. I am sure they will be looking at cvsg with interest now!! Huge companies such as Mars (already own 180 uk practices), Walmart etc are in this sector. |
Posted at 16/3/2024 06:37 by lomax99 CVS discount is too high, says LiberumThe discount at which veterinary group CVS (CVSG) trades is 'too high', given the competition watchdog's review into vet practices is likely to prove there is no case to answer, says Liberum.Analyst Seb Jantet retained his 'buy' recommendation and target price of £22 on the stock, which gained 1.4% to £14.92 at the end of last week after its interim results. The shares have shed 21% over the year following the Competitions & Markets Authority (CMA) decision to investigate whether vets were providing consumers with value for money.Jantet said there was not a lot of new information in the result but added that 'we are still waiting for the most important piece of information, being the CMA's initial decision which is still expected in early 2024'.'While the shares have recovered a little over the last few months, they are still trading on undemanding multiples both in absolute terms and in relation to historic ratings, on a current year 2024 embedded value to pre-tax profit multiple of 9.9 times,' he said.'While we accept that the CMA uncertainty warrants a discount over the historic rating of around 15 times, the discount looks too high to us, especially given our view that there is a good chance the CMA will conclude there isn't a case to answer when it next updates.' |
Posted at 13/3/2024 05:29 by undervaluedassets Well we now have a 2017 share priceAnd in 2017 the company had EPS of 18p, profits of 14 million and a 271 million turnover. Is that what we should expect? instead of the pencilled 80-90p in earnings on 50-90 million in profit on a turnover of 670 million? I do not see that being the case... Ergo .. cheap The market panicked today. In the past, I have done well out of buying into panics. |
Posted at 07/9/2023 10:40 by maywillow Michele MaatoukSharecast News 07 Sep, 2023 09:35 07 Sep, 2023 09:41 Pets at Home, CVS tumble as CMA launches review of vet services Shares of Pets at Home and CVS Group tumbled on Thursday after the Competition and Markets Authority said it was launching a probe into the £2bn veterinary services market for household pets. The competition watchdog said it will explore how well the market is working for pet owners and whether they are receiving the information they need at the right time to get appropriate treatment for their pets. The CMA said it was keen to hear more about pet owners’ and vet practitioners’ experiences of pricing of services, including whether pet owners were aware of how much a treatment would cost, and how they pay for it. It also wants to hear about how prescriptions and medication for pets are arranged and sold and how pet owners choose a vet surgery - whether they are aware that their vet may be part of a larger chain which might also own other surgeries in the area. The use of out-of-hours and emergency vet services where options might be limited will also be looked into. CMA chief executive Sarah Cardell said: "Caring for an ill pet can create real financial pressure, particularly alongside other cost of living concerns. It’s really important that people get clear information and pricing to help them make the right choices. "There has been a lot of consolidation in the vet industry in recent years, so now is the right time to take a look at how the market is working. "When a pet is unwell, they often need urgent treatment, which means that pet owners may not shop around for the best deal, like they do with other services. This means they may not have the relevant information to make informed decisions at what can be a distressing time. We want to hear from pet owners and people who work in the sector about their experiences." Pets at Home owns veterinary groups Companion Care Vets and Vets4Pets and has a network of more than 450 vet practices across the UK. CVS Group, meanwhile, is one of the largest integrated veterinary services providers in the UK. At 0925 BST, Pets shares were down 11.2% at 336.20p. Shares of AIM-listed vet services provider CVS Group were down 29% at 1,479.00p. Russ Mould, investment director at AJ Bell, said: "Being in the pets and vet space has felt like a healthy place to be in recent years. That’s been reflected in strong share prices for the likes of vet group CVS and Pets at Home which has its own veterinary arm within a broader retail and grooming offering. "Britons love their animal companions and are willing to pay up to keep them healthy and happy. "News that the competition authorities are looking into the rising costs and potentially anti-competitive practices in the industry has set the cat among the pigeons when it comes to the share prices of CVS and Pets at Home. "The sell-off seen today could be an overreaction, although the CMA review looks to be wide-ranging. The problem for both businesses is the process is likely to be time-consuming and, with a further update not due until early 2024, it could weigh on both stocks for some time to come." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
